Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.
D
D
Lawrence
Z
Z
Shahrokh
S
S
Marsters
K
K
Achilles
D
D
Shih
B
B
Mounho
K
K
Hillan
K
K
Totpal
L
L
DeForge
P
P
Schow
J
J
Hooley
S
S
Sherwood
R
R
Pai
S
S
Leung
L
L
Khan
B
B
Gliniak
J
J
Bussiere
C A
CA
Smith
S S
SS
Strom
S
S
Kelley
J A
JA
Fox
D
D
Thomas
A
A
Ashkenazi
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D051017:Apoptosis Regulatory Proteins; D004353:Drug Evaluation, Preclinical; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008024:Ligands; D008252:Macaca fascicularis; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D011994:Recombinant Proteins / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity; D012449:Safety; D053221:TNF-Related Apoptosis-Inducing Ligand; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity*
D051017:Apoptosis Regulatory Proteins; D008024:Ligands; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; C505654:Tnfsf10 protein, mouse; D014409:Tumor Necrosis Factor-alpha